Connecting Drug Delivery81

Issue No #81 December 11th, 2017

Issue 81 - Dec 2017

Inside the magazine

CONNECTED HEALTH – AN EFFECTIVE SOLUTION TO IMPROVE ADHERENCE

CONNECTED HEALTH – AN EFFECTIVE SOLUTION TO IMPROVE ADHERENCE

Sai Shankar details the problem of non-adherence, in particular in asthma and COPD, and how its solution, along with myriad other benefits, can be found in digital healthcare and connected devices.

NEIL WILLIAMS, MEDICOM INNOVATION PARTNER

NEIL WILLIAMS, MEDICOM INNOVATION PARTNER

In this interview with ONdrugDelivery Magazine, Williams discusses the crucial role connectivity is taking in the drug delivery device industry.

IMPROVING PATIENTS’ LIVES THROUGH CONNECTIVITY

IMPROVING PATIENTS’ LIVES THROUGH CONNECTIVITY

Eric Dessertenne and Matthieu Hamon look at the importance of increasing the connectivity of drug delivery devices to improve patient compliance in the area of chronic disease management. Biocorp aims to use innovations such as Datapen™ and EasyLog™ to help create patient-centric, interconnected care, known as 4P medicine.

SOFTWARE AND SERVICES – THE MISSING LINK FOR CONNECTED THERAPEUTICS

Alexander Dahmani

SOFTWARE AND SERVICES – THE MISSING LINK FOR CONNECTED THERAPEUTICS

Alexander Dahmani explains how the rise of smart devices and connectivity has enabled QuiO to develop ConnectedRx™, the first cloud platform designed for connected therapeutics, and discusses how ConnectedRx™ programmes can be a step towards solving the ongoing problem of adherence.

HOW CONNECTIVITY WILL REMODEL HEALTHCARE

Dr Marjorie Villien

HOW CONNECTIVITY WILL REMODEL HEALTHCARE

Marjorie Villien and Jerôme Mouly provide a forecast of the place of connectivity in the healthcare market and the significant changes it is likely to bring to both devices and the market itself.

THE PROMISE OF VOICE: CONNECTING DRUG DELIVERY THROUGH VOICE-ACTIVATED TECHNOLOGY

THE PROMISE OF VOICE: CONNECTING DRUG DELIVERY THROUGH VOICE-ACTIVATED TECHNOLOGY

Chris Franzese and Marty Coyne discuss the vast potential that voice-activated technologies, such as Amazon’s Alexa, have in the healthcare market. Running through the challenges posed by data security and human factors, they go on to explain how the rewards voice-activation offers are well worth the effort, spanning the drug delivery experience.

CONNECTIVITY IN DRUG DELIVERY

CONFERENCE REVIEW

Napoleon Monroe

CONNECTIVITY IN DRUG DELIVERY

Napoleon Monroe summarises the intensifying coverage of connectivity as a key theme at two recent drug delivery conferences he attended, Partnerships in Drug Delivery and PDA’s Universe of Prefilled Syringes and Injection Devices.

ENERGY HARVESTING: POWERING CONNECTED DRUG DELIVERY DEVICES

Charlotte Harvey

ENERGY HARVESTING: POWERING CONNECTED DRUG DELIVERY DEVICES

Charlotte Harvey examines the opportunities and practicalities of using energy harvesting technologies in drug delivery devices. With a specific focus on enabling connectivity functionality, Ms Harvey runs through the various aspects of energy harvesting and offers insight on whether it is the right choice for a new device development.

PARTNERING FOR BLUETOOTH: THE SMART ROAD TO CONNECTIVITY

Thomas Soederholm

PARTNERING FOR BLUETOOTH: THE SMART ROAD TO CONNECTIVITY

Thomas Soederholm explains how advances in wireless technology, such as new Bluetooth Low Energy chips and design tools, are now being used in wireless medical product development and how incorporating them can be made much easier by partnering with a specialist vendor.

DATA IS DRIVING THE FUTURE OF NEUROTECHNOLOGY WITH CRANIALCLOUD

DATA IS DRIVING THE FUTURE OF NEUROTECHNOLOGY WITH CRANIALCLOUD

Will Rosellini, Nexeon Medsystems, and Pierre-Francois D’Haese, Neurotargeting, discuss the neurotechnology market and how the Internet of Medical Things is creating exciting opportunities in the space. looking specifically at the collaboration centring Nexeon’s Deep Brain Stiumulation technology and Neurotargeting’s CrainialCloud.

Top